ARCH VENTURE FUND IX, L.P. - SCHEDULE 13D - VIR BIOTECHNOLOGY, INC.

Company

Vir Biotechnology, Inc.

Filed

November 8, 2019

Accession Number

0001072613-19-000288

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →